Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Reversal of Rocuronium in Awake Craniotomy
NCT05202899Phase 4Unknown
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Sep 2020
- Primary completion
- Feb 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in brain tumor, sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT05202899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05202899.